# Tenofovir Alafenamide (Biktarvy)

Source: https://ourhealthnetwork.com/drugs/tenofovir-alafenamide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Tenofovir Alafenamide?

Tenofovir Alafenamide (brand name: Biktarvy) is a human immunodeficiency viru nucleoside analog reverse transcriptase inhibitor. It is prescribed to treat acquired immunodeficiency syndrome, hepatitis b, chronic. Across the United States, 3,000 doctors prescribe Tenofovir to approximately 6,000 Medicare patients.

## Brand names

Biktarvy

## Indications

Tenofovir Alafenamide is prescribed for the treatment of acquired immunodeficiency syndrome, hepatitis b and chronic.

## Conditions treated

- [Acquired Immunodeficiency Syndrome](https://ourhealthnetwork.com/conditions/acquired-immunodeficiency-syndrome)
- [Hepatitis B](https://ourhealthnetwork.com/conditions/hepatitis-b)
- [Chronic](https://ourhealthnetwork.com/conditions/chronic)

## Mechanism of action

BIKTARVY is a fixed dose combination of antiretroviral drugs bictegravir (BIC), emtricitabine (FTC), and tenofovir alafenamide (TAF)  .

## Drug classification

- Established Pharmacologic Class: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Mechanism of Action class: Nucleoside Reverse Transcriptase Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

diarrhea, headache, nausea

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)